GR
Therapeutic Areas
RedHill Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Opaganib (ABC294640) | COVID-19 (Severe Hospitalized) | Phase 2/3 |
| Opaganib | Prostate Cancer | Phase 2 |
| RHB-107 (Upamostat) | COVID-19 (Non-Hospitalized) | Phase 3 |
| RHB-107 | Cancer (Solid Tumors) | Phase 1/2 |
| RHB-204 | Pulmonary Nontuberculous Mycobacteria (NTM) Disease | Phase 3 |
Leadership Team at RedHill Biopharma
DB
Dror Ben-Asher
Chief Executive Officer
MB
Micha Ben Chorin
Chief Financial Officer
RF
Reza Fathi
Senior VP, R&D